All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MDS Alliance.

The MDS Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Introducing

Now you can personalise
your MDS Hub experience!

Bookmark content to read later

Select your specific areas of interest

View content recommended for you

Find out more
  TRANSLATE

The MDS Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the MDS Hub cannot guarantee the accuracy of translated content. The MDS Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact
LOADING
You're logged in! Click here any time to manage your account or log out.
LOADING
You're logged in! Click here any time to manage your account or log out.
As of January 1st, 2024, the MDS Hub will no longer be updated. Please continue to browse our archive for valuable content. For the latest updates in MDS, visit our sister site aml-hub.com.

About the MDS Hub

The MDS Hub is an open-access online resource, dedicated to providing balanced, credible, and up-to-date medical education in myelodysplastic syndromes (MDS). Our aim is to enhance knowledge in MDS through the multichannel dissemination of global advances related to their classification, diagnosis, treatment, and management.
The MDS Hub shares new data, evidence-based articles, therapy approvals, expert opinions, and international congress coverage to treatment teams and researchers around the world.

Vision

For every treatment team and researcher to have instant access to expert opinions and the latest evidence-based information in MDS, to aid in treatment decisions and improve the lives of patients with MDS globally.

Mission

The MDS Hub is the solution for a time-stretched HCP to easily access impactful information that expedites learning and empowers their treatment decisions. Informed by patients, curated by world leaders and endorsed by expert societies the MDS Hub supports HCPs worldwide.

Partnerships

The MDS Hub was founded in partnership with the European LeukemiaNet (ELN). The ELN is a publicly-funded network of excellence, where clinicians and scientists improve therapy options for patients with leukemia worldwide. Together, they look to define strategies to improve leukemia characterization, its common diagnostic procedures and therapeutic standards, as well as to facilitate clinical and fundamental research. This approach results in the advancement of leukemia research and it supports equal access for all patients to the best possible care.

Brought to you by SES (scientific Education Support)

Independent medical education (IME), informed by patients, curated by world leaders, endorsed by expert societies. SES supports healthcare professionals and patients worldwide with up-to-date, accessible, and impactful educational content. Our hubs tackle information overload, providing a comprehensive central resource for healthcare professionals (HCPs) in specific disease areas that keep them up-to-date with the latest therapeutic news and world leading opinions. Endorsed by expert societies, and a member of the gCMEp, our platforms ensure credibility and trust. By identifying and filling knowledge gaps in easily digestible formats, we facilitate continuous learning, leading to improved patient outcomes.

The Scientific Education Support Team